LENALID 25 MG

About

LENALID 25 MG, containing Lenalidomide, is an immunomodulatory drug with significant anti-angiogenic, anti-neoplastic, and immunomodulatory properties. It is structurally related to thalidomide but possesses a distinct pharmacological profile and improved safety. Lenalidomide primarily works by modulating the immune system, inhibiting angiogenesis, and directly inducing apoptosis in certain cancer cells. It is a cornerstone in the treatment of multiple myeloma, where it enhances the activity of other anti-cancer agents and directly impacts myeloma cells. Additionally, it is highly effective in myelodysplastic syndromes (MDS) associated with a specific chromosomal deletion, del(5q), by promoting erythroid maturation and reducing transfusion dependence.

Its multifaceted mechanism of action involves altering cytokine production, enhancing T-cell and NK-cell mediated immunity, and inhibiting tumor cell proliferation. Due to its potent teratogenic potential, Lenalidomide is subject to a strict risk evaluation and mitigation strategy (REMS) program to prevent fetal exposure. Patients must adhere to strict contraception guidelines. Regular monitoring for hematological toxicities and thromboembolic events is also essential during treatment.

Uses

• Treatment of multiple myeloma in combination with dexamethasone.
• Management of myelodysplastic syndromes (MDS) with del(5q) cytogenetic abnormality.
• Therapy for mantle cell lymphoma (MCL) in patients whose disease has relapsed or progressed.
• Treatment of follicular lymphoma (FL) and marginal zone lymphoma (MZL) in combination.

Directions For Use

Take orally once daily, with or without food. Swallow the capsule whole with water.

Benefits

• Highly effective in multiple myeloma.
• Improves response rates in specific MDS.
• Possesses immunomodulatory effects.
• Exhibits anti-angiogenic properties.
• Convenient oral administration.
• Extends progression-free survival in various cancers.

Side Effects

• Neutropenia (low white blood cells)
• Thrombocytopenia (low platelets)
• Fatigue
• Diarrhea
• Constipation
• Skin rash
• Muscle cramps
• Peripheral neuropathy
• Deep vein thrombosis (DVT)
• Pulmonary embolism (PE)
• Dizziness
• Nausea

Safety Measures

• Alcohol - Avoid or limit alcohol consumption due to the potential for increased fatigue and gastrointestinal side effects while on this medication.
• Pregnancy - Absolutely contraindicated during pregnancy due to severe teratogenicity. Strict pregnancy prevention programs are mandatory for all patients.
• Breastfeeding - Not recommended during breastfeeding as it is unknown if Lenalidomide is excreted in breast milk, posing a potential risk of serious adverse effects to the infant.
• Liver - Use with caution in patients with liver impairment. Liver function should be monitored, and dose adjustments may be necessary in severe cases.
• Kidney - Use with caution in patients with kidney impairment. Renal function should be monitored closely, and dose adjustments are often required based on creatinine clearance.
• Lung - Increased risk of thromboembolic events (e.g., DVT, PE). Monitor for symptoms such as shortness of breath or chest pain.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.